PDRN vs PN for Cosmetics: Molecular Weight & Grade Selection

When a cosmetic brief calls for “salmon DNA,” formulators and buyers are often asked to choose between PDRN vs PN. In practice, the label alone rarely tells you enough. One supplier’s PDRN may differ from another supplier’s PN in molecular-weight range, processing method and supporting documentation. The boundary between the two terms is not always consistent across the market. A useful comparison therefore starts with the commercial grade, not the acronym. How is the material identified in the specification? What does the COA actually control? Is molecular weight reported as a defined range or only as a maximum value? Has the grade been evaluated in the intended serum, gel, mask essence or emulsion? CAS number, assay and molecular weight all matter—but only when they are considered together.

The Short Answer

PDRN commonly refers to DNA-derived material with shorter or more highly fragmented chains, while PN is often associated with longer-chain, higher-molecular-weight material. In practice, however, the terminology is not applied consistently by every supplier, and the molecular-weight ranges may overlap.

Neither name alone confirms the purity, molecular-weight distribution, microbiological quality or performance of a commercial grade. Formulators and buyers should compare the specification, COA and intended application—not choose a material by the acronym alone.

A CAS number helps identify a substance, but it does not define a commercial grade. This distinction is especially important for DNA-derived polymers, which do not consist of molecules with one fixed chain length. Materials listed under the same CAS number may still differ in molecular-weight distribution, biological source, processing, residual components, moisture, appearance and batch-release criteria. Matching CAS numbers alone therefore do not show that two grades are equivalent.

Renew’s cosmetic PDRN and PN grades (PDRN vs PN) provide a practical example. Both are listed under CAS 9007-49-2, but their current specifications use different average molecular-weight limits. For buyers, the CAS number is a starting point for identity review. The product specification defines the grade, while the batch COA shows whether the supplied lot meets that specification.

Ingredient naming is a separate issue. PDRN and PN are widely used technical and commercial descriptions, but they may not be the names used on a finished cosmetic ingredient list. The European Commission’s CosIng database includes SODIUM DNA/RNA; however, CosIng is an informational database and does not, by itself, confirm regulatory authorization or the correct declaration for every material. The appropriate ingredient name should be checked against the exact material composition, supplier documentation and the labelling requirements of the destination market.

These three levels are related, but they are not interchangeable. The 1,500 kDa cutoff comes from a 2025 narrative review. It is a proposed way to distinguish PDRN from PN, not an internationally adopted cosmetic standard.

Renew uses different limits for its current grades. Its PDRN grade has an average molecular-weight limit of ≤1,000 kDa. Its PN grade is specified at ≥1,000 kDa. These limits apply to Renew’s own product range. Buyers should therefore compare the full specification, test method, molecular-weight distribution and batch documentation.

A CAS number helps identify a substance, but it does not define a commercial grade. This distinction is especially important for DNA-derived polymers, which do not consist of molecules with one fixed chain length. Materials listed under the same CAS number may still differ in molecular-weight distribution, biological source, processing, residual components, moisture, appearance and batch-release criteria. Matching CAS numbers alone therefore do not show that two grades are equivalent.

Renew’s cosmetic PDRN and PN grades provide a practical example. Both are listed under CAS 9007-49-2, but their current specifications use different average molecular-weight limits. For buyers, the CAS number is a starting point for identity review. The product specification defines the grade, while the batch COA shows whether the supplied lot meets that specification.

Ingredient naming is a separate issue. PDRN and PN are widely used technical and commercial descriptions, but they may not be the names used on a finished cosmetic ingredient list. The European Commission’s CosIng database includes SODIUM DNA/RNA; however, CosIng is an informational database and does not, by itself, confirm regulatory authorization or the correct declaration for every material. The appropriate ingredient name should be checked against the exact material composition, supplier documentation and the labelling requirements of the destination market.

DNA-derived raw materials are normally polydisperse: one batch contains chains of different lengths. An “average molecular weight” is therefore a summary of a distribution, not a statement that every chain has the reported size. Two products with the same average may still have different dominant fractions, distribution widths and high- or low-molecular-weight tails.

Before comparing two reports, ask what the reported number represents. It may be number-average molecular weight, weight-average molecular weight, a peak value, a calculated range or a supplier-specific release result. Values reported in kDa and base pairs should not be compared without knowing whether a conversion was used and what structural assumptions were made.

The analytical method matters as well. Broad biological polymers can be difficult to characterize with one technique, and sample concentration, ionic conditions, aggregation and calibration can influence the result. A 2026 analytical study used orthogonal measurement approaches for PDRN, illustrating why a molecular-weight number should be reviewed together with the method and sample conditions.

For sourcing approval, the practical questions are:

• Is the result an average, a range, a peak or a distribution?
• Which analytical method and calculation basis were used?
• Does the report relate to the commercial batch being offered?
• Can at least two production batches be compared on the same basis?
• Could preparation, heat or shear change the polymer profile in the finished formula?

An assay limit such as NLT 90.0% can be useful only when the method and reporting basis are understood. One supplier may report on an as-is basis, another on a dry basis, and another may use a different analytical response or calculation. A UV absorbance ratio used for identity or spectral-purity review is also not the same thing as a quantitative DNA assay.

Buyers should ask what makes up the balance of the material. Depending on the grade and method, moisture, counterions, process-related components or other measured constituents may affect the reported percentage. The unreported balance should not automatically be described as harmful impurity, but it should be explained well enough for quality and regulatory review.

Much of the PDRN and PN literature comes from pharmaceutical preparations, injectable aesthetic products, cell models or animal studies. Those sources can explain scientific background, but they do not prove equivalent performance from a cosmetic powder applied in a conventional serum or cream. Injection bypasses the stratum corneum; topical application does not.

Lower molecular weight should therefore not be translated automatically into meaningful passage through intact skin. Likewise, higher molecular weight does not prove longer residence or scaffold behavior in a dilute topical formula. Claims must be supported by the exact raw material, delivery system, finished product and intended route.

Cosmetic-grade material must not be assumed suitable for injection. Sterility, endotoxin control, manufacturing quality, safety evidence and regulatory authorization are route-specific requirements and must be evaluated separately.

1. Define the finished-product format, target market and intended product claims before screening grades.
2. Confirm the material identity, biological source, supported ingredient declaration and supplier-specific definition of PDRN or PN.
3. Review assay and molecular-weight data only after checking the test method, calculation basis and units. Also confirm whether the figures are specification limits or batch-specific results.
4. Conduct side-by-side screening at the same concentration and under the same mixing conditions. Record appearance, odor, dissolution time, clarity and pH.
5. Test each shortlisted grade in the intended formula. Evaluate compatibility, viscosity, preservative performance and stability under the planned conditions.
6. For higher-risk or larger-volume projects, repeat the critical checks using a second production batch before final approval.

This process also makes price comparisons more meaningful. Price per kilogram matters, but it is only one part of the total development cost. Haze, odor, slow dissolution, viscosity drift, repeated laboratory work or batch variability may cost more than the initial difference in raw-material price.

Renew supplies separate cosmetic PDRN and PN grades under CAS 9007-49-2. Both grades have an assay specification of at least 90.0%. The main difference in Renew’s current specifications is the average molecular-weight limit.

These limits define Renew’s commercial grades and should not be treated as definitions used by every supplier. For grade selection, request the current specification, batch COA and a sample for formula evaluation.

To recommend a suitable grade and send the relevant documents, Renew needs a few details about your project. A finalized formula is not required. Please include whatever information is already available:

• Destination market and required cosmetic ingredient declaration, if known.
• Intended product format, such as a serum, ampoule, toner, gel, mask essence, cream or lotion.
• Target use level or screening concentration, if already established.
• Appearance requirements, particularly clarity, color and odor.
• Known formulation constraints, such as thickeners, cationic ingredients, electrolytes or the preservative system.
• Required specification items and supporting documents.
• Desired sample quantity and expected commercial volume, if known.

Even partial information helps our team narrow the grade options, identify possible compatibility questions and prepare a more relevant response. Renew can then provide the appropriate specification, available batch documents and sample support for your evaluation.

PDRN versus PN is not simply a choice between two acronyms. The decision should be based on the exact commercial grades being offered. Start by confirming the material identity and ingredient naming for the target market. Then compare the molecular-weight specification and test method, assay basis, biological source, formulation behavior and batch documentation.

The right grade is one that is clearly specified, supported by appropriate documentation and shown to perform reliably in the intended cosmetic formula.

If your team is comparing cosmetic PDRN and PN grades, explore Renew’s PDRN and PN raw-material range. Share your intended product format, destination market, target use level and key technical requirements with your inquiry. Renew can then provide the relevant grade specifications, available batch documentation and sample options for your evaluation.

This article distinguishes between chemical terminology, proposed scientific nomenclature and supplier-specific commercial grades. Renew product data refer to the grades described at the time of publication. Buyers should confirm the latest specification and batch documentation before approving a material.

• Marques, C. et al. “From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): A Proposed Nomenclature Framework.” Biomolecules. 2025;15(1):148.
• Kim, S.T. “Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives.” Pharmaceutics. 2025;17(8):1024.
• Chen, S. et al. “Orthogonal Molecular Weight Analysis of Challenging Macromolecules Using MALS and Mass Photometry: Example of Polydeoxyribonucleotide.” Biomacromolecules. 2026.
• European Commission. “CosIng entry: SODIUM DNA/RNA” and “Cosmetic Ingredient Database Notice.”
• U.S. Food and Drug Administration. “Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice” and “Pyrogen and Endotoxins Testing: Questions and Answers.”

Scope note: This article addresses the evaluation of cosmetic raw materials. It does not establish the regulatory status, safety or performance of a finished product. Finished-product manufacturers remain responsible for formulation testing, safety assessment, regulatory review and claims substantiation in the target market. Cosmetic grades discussed in this article are not intended for injection.